Here we first confirmed previous reports that Ang-2 and VEGF-A levels are increased in COVID-19 (Smadja et al., 2021; Vassiliou et al., 2021), extending these findings to include soluble Tie2 and soluble VEC levels. This evidence concerns the gene TEK and COVID-19.